CAPTRUST Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$490K Sell
4,615
-255
-5% -$27.1K ﹤0.01% 1743
2025
Q1
$605K Sell
4,870
-467
-9% -$58K ﹤0.01% 1535
2024
Q4
$657K Buy
5,337
+372
+7% +$45.8K ﹤0.01% 1463
2024
Q3
$553K Buy
4,965
+430
+9% +$47.9K ﹤0.01% 1517
2024
Q2
$484K Sell
4,535
-258
-5% -$27.5K ﹤0.01% 1522
2024
Q1
$577K Sell
4,793
-522
-10% -$62.9K ﹤0.01% 1417
2023
Q4
$654K Sell
5,315
-158
-3% -$19.4K ﹤0.01% 1542
2023
Q3
$708K Sell
5,473
-7,281
-57% -$942K ﹤0.01% 1414
2023
Q2
$1.58M Buy
12,754
+7,825
+159% +$970K 0.01% 932
2023
Q1
$721K Buy
4,929
+179
+4% +$26.2K ﹤0.01% 1211
2022
Q4
$757K Sell
4,750
-156
-3% -$24.9K ﹤0.01% 1123
2022
Q3
$654K Buy
4,906
+1,180
+32% +$157K ﹤0.01% 1119
2022
Q2
$581K Buy
3,726
+19
+0.5% +$2.96K ﹤0.01% 1081
2022
Q1
$577K Buy
3,707
+86
+2% +$13.4K ﹤0.01% 1084
2021
Q4
$461K Buy
3,621
+240
+7% +$30.6K ﹤0.01% 1166
2021
Q3
$440K Sell
3,381
-107
-3% -$13.9K ﹤0.01% 1097
2021
Q2
$620K Buy
3,488
+250
+8% +$44.4K 0.01% 910
2021
Q1
$532K Buy
3,238
+418
+15% +$68.7K 0.01% 935
2020
Q4
$465K Buy
2,820
+110
+4% +$18.1K 0.01% 861
2020
Q3
$391K Hold
2,710
0.01% 792
2020
Q2
$297K Sell
2,710
-605
-18% -$66.3K ﹤0.01% 873
2020
Q1
$317K Sell
3,315
-525
-14% -$50.2K 0.01% 707
2019
Q4
$570K Buy
3,840
+3,620
+1,645% +$537K 0.01% 648
2019
Q3
$28K Hold
220
﹤0.01% 1196
2019
Q2
$31K Buy
220
+120
+120% +$16.9K ﹤0.01% 1143
2019
Q1
$14K Sell
100
-14
-12% -$1.96K ﹤0.01% 1293
2018
Q4
$14K Buy
114
+14
+14% +$1.72K ﹤0.01% 1132
2018
Q3
$17K Buy
+100
New +$17K ﹤0.01% 1066